Transforming Rehabilitation Update

As part of Purple Futures, 3SC is currently managing a supply chain of delivery organisations across five regions. Purple Futures is a partnership of private sector, charities and social enterprises which has been providing probation and rehabilitation services on behalf of the Ministry of Justice since February 2015.

3SC has a further 99 organisations within the Transforming Rehabilitation (TR) supply chain. 3SC are currently contacting all of these organisations to arrange initial meetings to refresh the due diligence evidence and to ensure compliance. This includes undertaking a review of the services being offered and ensuring the listed geographic coverage of their provision is still correct.

3SC has also been working with the Community Rehabilitation Companies (CRC) to develop a needs analysis of the services required for the five regions. The results of the analysis will be used to develop future commissioning opportunities within the CRC. The opportunities will be opened up to all organisations within 3SC’s TR supply chain.

In addition one of 3SC’s core roles is to generate and keep updated a directory of services that has over 1,900 services available to help offenders with their transition back into the community. As part of the Transforming Rehabilitation agenda these services are creating a real step change in how rehabilitation services have historically been delivered, and include a wide range of housing, addiction, benefits, children’s and families, domestic abuse, health and wider welfare and employment services.

To date, the Purple Futures Innovation Panel has approved over £293,000 in grants that go directly into VCSEs to help them deliver and develop innovative services.  A further 10 applications worth £382,000 have been submitted for the January Panel. Decisions will be announced in January. The panel is chaired by Mark Simms – CEO of P3 and includes Kim Thornden-Edwards – Purple Futures Service Delivery Director, Tracy Davis- Head of TR for 3SC and representatives from CRCs.